Floatz logo

36 assets in Brain Cancer

Therapeutic assets addressing Brain Cancer, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Irinotecan
Brain Cancer
University of California, DavisP2BBB (72)
Cediranib
Brain Cancer
National Cancer Institute (NCI)P2BB (71)
Cyclophosphamide
Brain Cancer
Essen BiotechP2BB (65)
Capecitabine
Brain Cancer
Northwell HealthP2B (61)
Carboplatin
Brain Cancer
John L. Villano, MD, PhDP3B (61)
Pembrolizumab
Brain Cancer
Essen BiotechP2B (60)
Vorinostat
Brain Cancer
Duke UniversityP2B (60)
Niraparib
Brain Cancer
Ivy Brain Tumor CenterP3B (59)
Cetuximab
Brain Cancer
Northwell HealthP2B (58)
Mannitol
Brain Cancer
Northwell HealthP2B (57)
Rvp-001
Brain Cancer
Reveal Pharmaceuticals Inc.P2B (57)
Fludarabine
Brain Cancer
Essen BiotechP1/2CCC (55)
Aguix
Brain Cancer
Brigham and Women's HospitalP2CCC (53)
Ruxolitinib
Brain Cancer
Baptist Health South FloridaP2CCC (53)
Sgm-101
Brain Cancer
Leiden University Medical CenterP2CCC (53)
Silevertinib
Brain Cancer
Black Diamond Therapeutics, Inc.P2CCC (53)
Trastuzumab Deruxtecan
Brain Cancer
Memorial Sloan Kettering Cancer CenterP2CCC (53)
LMP744
Brain Cancer
National Institute of Neurological Disorders and Stroke (NINDS)P1/2CC (45)
st101
Brain Cancer
Sapience TherapeuticsP1/2CC (45)
TIL
Brain Cancer
Essen BiotechP1/2CC (45)
azd1390
Brain Cancer
AstraZenecaP1CC (43)
Definity
Brain Cancer
Sunnybrook Health Sciences CentreP1CC (43)
Dri Cell Therapy
Brain Cancer
University of Alabama at BirminghamP1CC (43)
Fapi-46
Brain Cancer
Jonsson Comprehensive Cancer CenterP1CC (43)
Ad5-yCD
Brain Cancer
Henry Ford Health SystemP1CC (41)
ad5-ycd/muttksr39rep-adp adenovirus
Brain Cancer
Henry Ford Health SystemP1CC (41)
Antigen-Specific Igt Cells
Brain Cancer
Shenzhen Geno-Immune Medical InstituteP1CC (41)
Fludeoxyglucose
Brain Cancer
Jonsson Comprehensive Cancer CenterP1CC (41)
mk-3475
Brain Cancer
Dana-Farber Cancer InstituteP1CC (41)
Rqnestin
Brain Cancer
Dana-Farber Cancer InstituteP1CC (41)
Panitumumab-Irdye800
Brain Cancer
Eben RosenthalEarly P1C (38)
R130
Brain Cancer
Shanghai Yunying Medical TechnologyEarly P1C (38)
Autologous Nk Cells
Brain Cancer
Peking University Third HospitalN/AD (30)
Soluble Fluorescein
Brain Cancer
Mayo ClinicN/AD (30)
mt027
Brain Cancer
Suzhou Maximum Bio-tech Co., Ltd.P1NR ()
Nbm-Bmx
Brain Cancer
Novelwise Pharmaceutical CorporationP1/2NR ()